High GLUD1 expression or low SLC25A13 expression was found to be associated with tumor aggressiveness, including depth of tumor invasion, lymph node and distant metastasis, lymphatic and venous invasion, and stage (Supplementary Table S2). This evidence concerns the gene SLC25A13 and neoplasm.